Alison Darcy, Researcher and Psychologist

Clinical research psychologist Dr. Alison Darcy is the CEO and creator of Woebot Labs, Inc., a business that seeks to drastically increase everyone’s access to the greatest psychological tools. She developed the amiable AI-powered chatbot Woebot, which offers cognitive behavior therapy on a large scale. During her ten years as a faculty member in psychiatry and behavioral sciences at Stanford School of Medicine, clinical research psychologist Alison created digital health interventions for adolescents. Alison is a technology and mental health professional with a background in both science and technology.

2023

In the seventh edition of the MedTech Breakthrough Awards, an independent market intelligence company that honors the best businesses, innovations, and goods in the international health and medical technology sector, Woebot Health announced that it has been chosen as the winner of the “Best Overall Mental Health Solution” category.

Woebot Health creates evidence-based, totally automated behavioral health solutions to assist individuals in overcoming difficult emotions, beliefs, and habits. Health systems and plans may enhance the current care route, increase engagement and satisfaction, and enable patients “talk” their way through self-guided therapy with the use of the company’s patented conversational interface and natural language processing capabilities. In order to generate more accurate and tailored programs that match populations with varying profiles and requirements, Woebot Health’s solutions are created by intervention scientists and clinicians who are always testing and adding best-in-class clinical procedures.

Latest news about Alison Darcy

• Phare Health, a London-based AI company, has closed a €2.8 million seed funding round led by General Catalyst. The funding will be used to drive AI innovation and foster partnerships within the UK’s National Health Service and internationally. The company aims to enhance operational efficiency by leveraging AI for non-clinical tasks, bridging the gap between clinicians and hospital operations. The funding will also support the expansion of Phare Health’s team.
• The World Health Organization (WHO) has released guidelines for regulating AI in the healthcare sector, emphasizing the need for transparency, ethical, and secure deployment. The guidelines call for open dialogues among stakeholders, including developers, regulators, manufacturers, healthcare professionals, and patients. AI has the potential to revolutionize healthcare by enhancing clinical trials, improving medical diagnostics, empowering self-care, and providing person-centered care. However, the rapid deployment of AI technologies presents challenges, including unethical data collection, cybersecurity threats, and amplifying biases.
• AstraZeneca has launched Evinova, a health-technology division integrating digital solutions and artificial intelligence into clinical trials. The division aims to reduce costs and duration for trials, reducing recruitment requirements. Evinova will integrate AstraZeneca’s clinical and regulatory experience with digital technology expertise. The division will offer personalized scientific services, remote patient monitoring, trial design, and consulting services. The digital health market is expected to reach $900 billion by 2032.

Latest Social posts of Alison Darcy